Dan Schell recounts some of his key takeaways after attending the Veeva R&D Quality Summit in Boston in September 2024. Some of the topics discussed include DCTs, eCOA, and the need to simplify tech integration at sites.
- Early Planning Trumps eCOA Bells & Whistles
- Why We Need Technology Consolidation In Clinical Trials
- Is Blockchain The Solution To Derisking Unreliable Clinical Trial Data?
- A Quick & Easy Guide To Site-Facing Clinical Trial Technologies
- What Sites Need: Trial Technology Integration, Support, And Evaluation
- Some Truths You Can't Avoid About eCOA
- What Sites Need: Trial Technology Selection, Buy-In, And Implementation
- Managing Risk In New And Emerging Trial Technology Trends
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
RTSM: Randomization And Cohort Management, IP Inventory Management
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Simplify Clinical Trials With Signant SmartSignals® Unified Platform
Signant SmartSignals® Unified Platform streamlines clinical trials by integrating eConsent, data collection, remote consultations, and randomization, simplifying workflows for patients and site staff.
-
eCOA Risk Management In The Digital Age
Regulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.
-
How Capturing Data Directly Is Transforming Trials
With the right eSource technology, discover how trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.
-
Providing Drug Supply Support In Complex Environments Through IRT
Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
RTSM And Clinical Drug Dispensation
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Digitizing Multilingual COAs: A Practical Guide
With pen and paper becoming obsolete in the digital era, shifting to electronic Clinical Outcome Assessments (eCOAs) is becoming more critical than ever. Download the available checklist for a guide through the four main steps required to ensure a successful English build and language migration.
-
How Real-Time eTMFs Are Helping Keep Trials On Track
Learn how real-time dashboards assist with the sorting of information so clinical trial and medical affairs teams know what needs to be done, when, and by whom.
-
Broadening Eligibility Criteria And Diversity Among Patients For Cancer Clinical Trials
This study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.
-
Implementing Cognizant® Shared Investigator Platform: Lessons From The Field
One leading oncology healthcare system and research institution has recently successfully implemented Cognizant SIP and shares its best practices around planning for and implementing Cognizant SIP given such a large footprint.
FREE E-BOOK
ISR Reports recently conducted research to understand the pharma industry’s experiences with clinical technology providers. Based on their findings, they created Industry Perspectives On Clinical Technologies, an e-book that discusses characteristics to consider when selecting an IRT provider, why sponsors use more than one CTMS solution, the future of EDC, and more.
Read The E-book!